Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
Aloman
Costica
C
Liver Research Center, Brown Medical School, Providence, RI, USA.
Wands
Jack R
JR
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D015684:Gene Products, pol / Q000235:genetics; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D019259:Lamivudine / Q000627:therapeutic use*; D009154:Mutation; D063065:Organophosphonates
D000998:Antiviral Agents; D004279:DNA, Viral; D015684:Gene Products, pol; D063065:Organophosphonates; C066027:P protein, Hepatitis B virus; D019259:Lamivudine; D000225:Adenine; C106812:adefovir dipivoxil